Brett Matthew Hall - 20 Jun 2025 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
CHIEF SCIENTIFIC OFFICER
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Brett Matthew Hall
Issuer symbol
IMRX
Transactions as of
20 Jun 2025
Transactions value $
$34,616
Form type
4
Filing time
24 Jun 2025, 09:01:43 UTC
Previous filing
07 Feb 2025
Next filing
17 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hall Brett Matthew CHIEF SCIENTIFIC OFFICER 245 MAIN STREET, SECOND FLOOR, CAMBRIDGE /s/ Michael D. Bookman, Attorney-in-Fact for Brett Matthew Hall 24 Jun 2025 0001870437

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMRX Class A Common Stock Purchase $20K +7.42K +2.14% $2.70 353K 20 Jun 2025 Direct
transaction IMRX Class A Common Stock Purchase $14.6K +6.01K +1.7% $2.43 359K 23 Jun 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades through a broker-dealer at prices ranging from $2.4101 to $2.4299. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price.